257 related articles for article (PubMed ID: 29514220)
21. lncRNA CASC2 suppresses the growth of hemangioma cells by regulating miR-18a-5p/FBXL3 axis.
Dai YX; Qiu MK; Wang SQ; Pan C; Wang Y; Ou JM
J Biol Regul Homeost Agents; 2020; 34(1):49-56. PubMed ID: 32138500
[TBL] [Abstract][Full Text] [Related]
22. CASC2 inhibits the growth, migration, and invasion of thyroid cancer cells through sponging miR-18a-5p/FIH1 axis.
Liu QY; Gao LY; Xu L; Zhang XL; Zhang LJ; Gong XL; Luo SB; Zhao R; Cheng RC
Kaohsiung J Med Sci; 2021 Apr; 37(4):268-275. PubMed ID: 33336500
[TBL] [Abstract][Full Text] [Related]
23. lncRNA CASC2 Enhances
Tao L; Tian P; Yang L; Guo X
Biomed Res Int; 2020; 2020():7183629. PubMed ID: 33134385
[TBL] [Abstract][Full Text] [Related]
24. Long Noncoding RNA Taurine-Upregulated Gene1 (TUG1) Promotes Tumor Growth and Metastasis Through TUG1/Mir-129-5p/Astrocyte-Elevated Gene-1 (AEG-1) Axis in Malignant Melanoma.
Long J; Menggen Q; Wuren Q; Shi Q; Pi X
Med Sci Monit; 2018 Mar; 24():1547-1559. PubMed ID: 29543785
[TBL] [Abstract][Full Text] [Related]
25. LncRNA MIR205HG regulates melanomagenesis via the miR-299-3p/VEGFA axis.
Guo J; Gan Q; Gan C; Zhang X; Ma X; Dong M
Aging (Albany NY); 2021 Feb; 13(4):5297-5311. PubMed ID: 33535182
[TBL] [Abstract][Full Text] [Related]
26. RNPC1 inhibits non-small cell lung cancer progression via regulating miR-181a/CASC2 axis.
Yang L; Zhang Y; Ling C; Heng W
Biotechnol Lett; 2018 Mar; 40(3):543-550. PubMed ID: 29288351
[TBL] [Abstract][Full Text] [Related]
27. CASC2: An emerging tumour-suppressing long noncoding RNA in human cancers and melanoma.
Yu X; Zheng H; Tse G; Zhang L; Wu WKK
Cell Prolif; 2018 Dec; 51(6):e12506. PubMed ID: 30094876
[TBL] [Abstract][Full Text] [Related]
28. Berberine Promotes Apoptosis of Colorectal Cancer via Regulation of the Long Non-Coding RNA (lncRNA) Cancer Susceptibility Candidate 2 (CASC2)/AU-Binding Factor 1 (AUF1)/B-Cell CLL/Lymphoma 2 (Bcl-2) Axis.
Dai W; Mu L; Cui Y; Li Y; Chen P; Xie H; Wang X
Med Sci Monit; 2019 Jan; 25():730-738. PubMed ID: 30681073
[TBL] [Abstract][Full Text] [Related]
29. LncRNA AFAP1-AS Functions as a Competing Endogenous RNA to Regulate RAP1B Expression by sponging miR-181a in the HSCR.
Chen G; Peng L; Zhu Z; Du C; Shen Z; Zang R; Su Y; Xia Y; Tang W
Int J Med Sci; 2017; 14(10):1022-1030. PubMed ID: 28924375
[No Abstract] [Full Text] [Related]
30. LncRNA CASC2 inhibits cell proliferation, metastasis and EMT through miR-18a/SOCS5 axis in cholangiocarcinoma.
Peng L; Liu YH; Nie S; Gao M
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8367-8376. PubMed ID: 32894543
[TBL] [Abstract][Full Text] [Related]
31. The lncRNA CCAT1 Upregulates Proliferation and Invasion in Melanoma Cells via Suppressing miR-33a.
Lv L; Jia JQ; Chen J
Oncol Res; 2018 Mar; 26(2):201-208. PubMed ID: 28409554
[TBL] [Abstract][Full Text] [Related]
32. LncRNA FOXD3-AS1 promotes proliferation, invasion and migration of cutaneous malignant melanoma via regulating miR-325/MAP3K2.
Chen X; Gao J; Yu Y; Zhao Z; Pan Y
Biomed Pharmacother; 2019 Dec; 120():109438. PubMed ID: 31541886
[TBL] [Abstract][Full Text] [Related]
33. LncRNA CASC2 inhibited the viability and induced the apoptosis of hepatocellular carcinoma cells through regulating miR-24-3p.
Fan JC; Zeng F; Le YG; Xin L
J Cell Biochem; 2018 Aug; 119(8):6391-6397. PubMed ID: 29091305
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA PTTG3P functions as an oncogene by sponging miR-383 and up-regulating CCND1 and PARP2 in hepatocellular carcinoma.
Zhou Q; Zhang W; Wang Z; Liu S
BMC Cancer; 2019 Jul; 19(1):731. PubMed ID: 31340767
[TBL] [Abstract][Full Text] [Related]
35. SP1-induced up-regulation of lncRNA LUCAT1 promotes proliferation, migration and invasion of cervical cancer by sponging miR-181a.
Zhang L; Liu SK; Song L; Yao HR
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):556-564. PubMed ID: 30831032
[TBL] [Abstract][Full Text] [Related]
36. LncRNA CASC2 expression is down- regulated in papillary thyroid cancer and promotes cell invasion by affecting EMT pathway.
Zhou T; Zhong M; Zhang S; Wang Z; Xie R; Xiong C; Lv Y; Chen W; Yu J
Cancer Biomark; 2018; 23(2):185-191. PubMed ID: 30175973
[TBL] [Abstract][Full Text] [Related]
37. LINC00518 affects the proliferation, invasion and migration of cutaneous malignant melanoma cells via miR-526b-3p/EIF5A2 axis.
Xu J; Zhang F; Lin M; Tong Y
Acta Biochim Pol; 2022 Feb; 69(1):101-111. PubMed ID: 35189053
[TBL] [Abstract][Full Text] [Related]
38. The miR-181 family promotes cell cycle by targeting CTDSPL, a phosphatase-like tumor suppressor in uveal melanoma.
Zhang L; He X; Li F; Pan H; Huang X; Wen X; Zhang H; Li B; Ge S; Xu X; Jia R; Fan X
J Exp Clin Cancer Res; 2018 Jan; 37(1):15. PubMed ID: 29382357
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-485-5p represses melanoma cell invasion and proliferation by suppressing Frizzled7.
Wu J; Li J; Ren J; Zhang D
Biomed Pharmacother; 2017 Jun; 90():303-310. PubMed ID: 28364602
[TBL] [Abstract][Full Text] [Related]
40. miR-128 targets the CC chemokine ligand 18 gene (CCL18) in cutaneous malignant melanoma progression.
Song H; Tao Y; Ni N; Zhou X; Xiong J; Zeng X; Xu X; Qi J; Sun J
J Dermatol Sci; 2018 Sep; 91(3):317-324. PubMed ID: 30025750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
